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Abstract
Background: In Tanzania, malaria is the major cause of morbidity and mortality, accounting for about 30% of all
hospital admissions and around 15% of all hospital deaths. Severe anaemia and cerebral malaria are the two main
causes of death due to malaria in Tanga, Tanzania.
Methods: This was a prospective observational hospital-based study conducted from October 2004 to September
2005. Consent was sought from study participants or guardians in the wards. Finger prick blood was collected
from each individual for thick and thin smears, blood sugar levels and haemoglobin estimations by Haemocue
machine after admission.
Results: A total of 494 patients were clinically diagnosed and admitted as cases of severe malaria. Majority of them
(55.3%) were children below the age of 5 years. Only 285 out of the total 494 (57.7%) patients had positive blood
smears for malaria parasites. Adults aged 20 years and above had the highest rate of cases with fever and blood
smear negative for malaria parasites. Commonest clinical manifestations of severe malaria were cerebral malaria
(47.3%) and severe anaemia (14.6%), particularly in the under-fives. Case fatality was 3.2% and majority of the
deaths occurred in the under-fives and adults aged 20 years and above with negative blood smears.
Conclusion: Proper laboratory diagnosis is crucial for case management and reliable data collection. The non-
specific nature of malaria symptomatologies limits the use of clinical diagnosis and the IMCI strategy.
Strengthening of laboratory investigations to guide case management is recommended.
Background
Malaria is the leading cause of morbidity and mortality
affecting about 300-400 million people worldwide and
accounts for about 1-2 million deaths every year. It is also
the most prevalent tropical disease especially in sub-
Saharan Africa [1,2]. Major causes of malaria related
deaths are severe anaemia and cerebral malaria [3-8].
According to Annual report from Bombo regional hospital
for the year 2000, clinically diagnosed malaria accounted
for 59.9% of all admissions of which 21.6% had had the
severe form of the disease. Anaemia contributed 18.6% of
all admissions. There were 228 deaths reported in the pae-
diatric ward of which 33.3% were due to anaemia that was
most likely caused by malaria. Causes of severe malaria
other than anaemia accounted for 30.7% of all reported
deaths [9].
Due to their low acquired immune status, children
below five years of age are the most affected by malaria
in high transmission areas, whereas in low transmission
areas all age groups are equally affected [10,11]. Although
health facility-based reports show that malaria is the
leading cause for hospital attendance and admissions,
several studies across Africa indicate that the disease is
declining [12-14]. This has also been found in two
recently conducted studies at one health facility in the
city of Tanga (Makorora Health Centre), where only 10%
of patients screened in one study were positive for
malaria parasites [15], and in the other study (Msangeni
et al, unpublished) data collection activities had to be
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stopped after failure to obtain suitable candidates despite
most of the patients having clinical symptoms suggestive
of malaria.
Apart from these two studies which have shown very
low malaria prevalence, there is still inadequate informa-
tion on the epidemiology of laboratory confirmed malaria
and the underlying associated risk factors. It was the
objective of this study, therefore, to determine the malaria
disease pattern and the proportion of malaria associated
deaths in patients admitted at Bombo regional hospital.
The study was conducted for a period of one year from
October 2004 to September 2005 and involved prospective




The study was conducted in the city of Tanga, at Bombo
regional hospital, north-eastern Tanzania. The city lies at
about 5.17°, 5.33°S and 38.17°, 38.33°E along the Indian
Ocean seashore. The area receives two seasons of rainfall;
short rains during the months of October - December and
long rains in March - June, with a humidity of about
100%. Temperature ranges between 27°C and 32°C. Tanga
city covers an area of about 600 sq. km and has an esti-
mated human population of 248,696 (2003 estimated at a
growth rate of 2.1% per annum). The hospital has a capa-
city of 500 beds for inpatients among which 60 beds are
reserved for paediatric patients. It has a general laboratory
for both in-patient and out-patient services.
Based on data from Bombo regional hospital for the year
2003, malaria was indicated as the leading cause of hospi-
tal admissions in the intensive care unit (ICU), medical
and paediatric wards, accounting for 56.8%, 39.0% and
47.5% respectively. Severe anaemia and severe malaria
were noted to be the leading cause of deaths in the paedia-
tric ICU with rates of 61.5% and 45.8% respectively. Anae-
mia was most probably related to malaria, especially in
children.
Study design
This was a prospective observational hospital based study
conducted from 2004 to September 2005. Malaria case
admissions and outcome were collected and analysed.
The data were collected during official working hours
and only on five working days of the week.
Ethical consideration
Study aims were explained to Bombo hospital manage-
ment team in order to make them aware and get fully
involved in the study execution. Permission to conduct
the study in Bombo regional hospital was sought from
the Regional and City administrative authorities. During
all these meetings, study aims and activities were
elaborated and clarified when necessary. Oral and written
consents were sought from the study participants or
guardians/caretakers in the wards. Consent for adult
patients with cerebral involvement was sought through
relatives/caretakers. Patients’ data were taken as confi-
dential entities. The study was granted ethical clearance
by the Medical Research Co-ordinating Committee of the
National Institute for Medical Research.
Clinical and laboratory data collection
Patients were admitted at the out-patient department
(OPD), usually by clinical officers. The study group com-
prised of all patients admitted with a clinical diagnosis of
severe malaria. Both sexes and all ages were eligible for
inclusion in the study. Proposed diagnoses by the hospital
staff were entered in the morbidity form as they were.
Morbidity questionnaire was completed for all malaria
admissions in the wards. Clinical reassessment and labora-
tory investigations were done in the ward by the research
team. From each individual, personal data including name,
sex, age, ward, village/street, as well as clinical and parasi-
tological examination results were entered in the morbid-
ity form. Clinical notes of every patient were reviewed on
discharge to see if there was any re-evaluation and subse-
quent change of the initial diagnosis. Patients who had a
change of diagnosis from malaria to another febrile illness
on discharge were excluded from the study. Cerebral
involvement was assessed using Blantyre coma score
[16,17] by investigators.
Finger prick blood was collected from each individual
for thick and thin smears. For all cases, finger prick
blood was also taken for Hb level and blood sugar exami-
nations using Haemocue machine. The blood smears
were stained using 10% Giemsa for 30 minutes and
examined under the microscope for identification and
enumeration of malaria parasites. Malaria parasites were
counted against 200 leukocytes. A blood smear was con-
sidered negative if no malaria parasites were seen after
scanning 200 high power fields. When sexual parasites
were present, they were enumerated against 500 leuko-
cytes. Hyperparasitaemia was defined as parasite density
≥ 250,000 rings/μL of blood [18]. Anaemia was defined
as Hb < 11 g/dL [19,20]. Severe anaemia was classified as
Hb < 5 g/dL [21] whereas Hb between 5 g/dL and Hb <
11 g/dL was termed as mild/moderate anaemia [8,22].
Hypoglycaemia was defined as blood glucose < 2.2
mmole/L or < 40 mg/dL [18,23]. Fever was defined
as body temperature ≥37.5°C and hyperpyrexia as tem-
perature ≥ 39.5°C [18]. Severe malaria was reassessed
according to WHO 2000 guidelines [18]. In adults, sple-
nomegaly was defined as palpable spleen of any size but
for children we considered splenomegaly when the size
of the spleen exceeded 2 cm below the left costal margin.
Spleen enlargement was scored according to Hackett’s
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classification. Deaths which occurred during data collec-
tion period were also recorded.
Treatment of severe cases in the hospital
Initial assessment was done at the OPD on admission to
ascertain the presence of any severe signs which would
require special attention. Parenteral/oral paracetamol was
prescribed as antipyretic and analgesic whereas parent-
eral diazepam was prescribed to patients presenting with
convulsions. Blood transfusion was provided in the case
of severe anaemia (Hb < 5 g/dL) after screening for HIV,
grouping and cross-matching of the blood. According to
national policy quinine is the drug of choice. The drug is
administered by loading and maintenance doses. There is
a slight difference between the regimen for adults and for
children. The loading dose for adults is 20 mg/kg body
weight of quinine hydrochloride salt diluted in 10 ml/kg
of 5% dextrose by intravenous infusion. The drip is left to
run for over 4 hours. A maintenance dose of quinine fol-
lows 8 hours from the beginning of the previous (loading)
dose and is given at 10 mg/kg in similar IV drip, again
running over 4 hours. The maintenance dose is repeated
every 8 hours, calculated from the beginning of the pre-
vious infusion, until patient improves to an extent that
he can swallow. Then oral quinine (tablets), 10 mg salt/
kg, is given 8 hourly intervals to complete a 7 days treat-
ment course. As for children, a loading dose of quinine is
administered exactly like in adults (20 mg/kg), running
over 4 hours, followed by a maintenance dose (10 mg/kg)
12 hours after the start of the loading dose, given over 2
hours. This maintenance dose is repeated every 12 hours,
estimated from the beginning of the previous drip. When
the patient improves and can swallow, the quinine dose
is given orally, 10 mg/kg 8 hourly to complete a 7 day
treatment course.
Data management and analysis
Data collected from this study were handled using Epi-info
software and were double entered to minimize errors dur-
ing data entry process while check files were created to
restrict entrance of invalid data. Data analysis was done
using STATA version 9. Proportions were compared by
chisq test. Logistic regression analysis was used to com-
pare malaria clinical signs and symptoms with blood
smear results in patients admitted for severe malaria.
P-value < 0.05 was considered significant.
Results
Patient characteristics and malaria
A total of 494 patients were clinically diagnosed and
admitted as cases of severe malaria during the one year
period. Males accounted for 61.5% (304) of the patients.
Among the patients admitted to IPD, children aged 1-4
years were majority (34.4%), while children in the age
group 5-9 years were the least (13.6%), Table 1. Most of
the patients 77.5% (383) came from within the urban set-
tings of Tanga city. A total of 245 (49.2%) patients from
both rural and urban settings reported to have taken Sul-
phadoxine/pyrimethamine or Amodiaquine prior to
admission (Table 1).
Overall, 57.7% (285) of the cases had positive blood
smears for malaria parasites. Plasmodium falciparum and
P. malariae were the only malaria parasites species
detected. P. malariae was only found as mixed infection
and it accounted for 6.7% (19) of all infections. Highest
smear positive rate was recorded in children under the
age of 5 years and thereafter, the prevalence showed a
sharp drop that levelled off after the age of 10 years
(Table 1).
The highest parasite density of 10734 asexual para-
sites/μL (95% CI: 3912 - 33307) was recorded in patients
aged 10-19 years whilst the lowest parasite density (2158
asexual parasites/μL, 95% CI: 956 - 5363) was seen in
adults aged ≥20 years, (Table 1).
Fever and malaria parasites
About 70% of the patients admitted with a diagnosis of
severe malaria had fever (axillary temperature ≥ 37.5°C).
The highest rate of fever was recorded in children aged
1-4 years followed by infants and adults aged ≥20 years.
Figure 1 shows results of fever in association with blood
smears. Children in age group 1-4 years had the highest
fever prevalence in association with blood smear (BS)
positive for malaria parasites (Figure 1). Adults aged ≥20
years had a high proportion of negative BS with no fever
whereas children aged 5-9 years had the lowest rate of
both fever and malaria parasites.
Anaemia
Anaemia was a prominent feature among the patients,
with an overall rate of 69.8% (345). Only 30.2% (149/494)
of the patients had normal Hb levels (Hb > 11 g/dL).
Majority (55.2%) of the cases had mild/moderate anaemia.
Severe anaemia was recorded in 14.6% (72) of the patients
and a significant proportion of them (84.7%, p = 0.001)
had positive BS for malaria parasites. The prevalence of
severe anaemia was highest in children under the age of
5 years and decreased with increasing age.
Severe malaria manifestations
Following clinical reassessment of patients in the ward,
the proportion of patients with a clinical confirmed
diagnosis of severe malaria was 74.7% (369), (Table 2).
Out of 369 cases, a significant proportion (61.5%) had
positive BS for malaria parasites (p = 0.003). Most of
these patients were children below the age of 5 years.
Assessment by the Blantyre coma scale revealed that
129 out of total 273 under-fives (47.3%) admitted had
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signs and symptoms indicative of cerebral malaria but
only 89 of the 129 children (69.0%) had positive BS for
malaria parasites (Table 2).
Hyperpyrexia, hyperparasitaemia, hypoglycaemia, con-
vulsions and jaundice were among the accompanying clin-
ical complications of severe malaria observed across all
age groups. Among all these complications, hyperpyrexia
appeared to be relatively high (19.6%) (Table 2). Again, the
proportion of patients having any of these conditions with
malaria parasitaemia was not significant. Fever was identi-
fied in 70.5% (348) of cases but the proportion of those
with positive BS for malaria parasites was significantly
higher (p = 0.006) only in infants (Table 2 & 3). Hyperpyr-
exia was most prominent in those with positive BS with
the exception of infants and the adult age groups who
showed comparatively higher proportions of hyperpyrexia
in those with negative BS. Hypoglycaemia was not a major
clinical problem as it was seen only in 5 out of the 494
(1%) patients of whom only one had positive BS for
malaria parasites. Only 4 out of the 494 (0.8%) patients
recruited had hyperparasitaemia, and all of them were
children under the age of five years. There was a signifi-
cantly higher proportion (85.5%) of children aged 1-4 with
both malaria and enlarged spleen (p = 0.001) as shown in
Table 3.
Duration of illness
The majority of patients in the study had been sick for
varying lengths before admission, ranging from 1 to 90
days. The longest period of sickness was documented in
adults of 20 years and above who had a median duration
of sickness of 7 [IQ range: 4-33] days. On the other
hand, a high proportion of the adults aged 20 years and
above gave a history of being sick for durations exceed-
ing 2 weeks (Table 4). Generally, the proportion of days
of illness seemed to increase with advancing age. Major-
ity of the patients who had positive BS for malaria para-
sites on admission claimed to have been sick for periods
not exceeding one week except a few in the age group
of 1-4 years, 10-19 years and adults of 20 years and
above. Patients who were admitted with negative BS for
malaria parasites reported the longest periods of sick-
ness, the mean duration increasing progressively from
5.6 [95% CI 4.2 - 7.0] days in infants to 21.8 [95% CI 15
- 28.2] days in adults aged 20 years and above (Table 4).
Deaths
Most of the patients (95.8%) were successfully treated
and discharged. However, 5 (1.0%) were transferred to
other health facilities for various reasons and 16 (3.2%)
Table 1 Demographic characteristics of patients initially admitted with a diagnosis of severe malaria
Age groups
Variable Overall Infants 1-4 years 5-9 years 10-19 years 20+ years
Number enrolled 494 103 170 36 67 118
Sex ratio (M/F) 1.6:1 2:01 1:01 1:02 3.5:1 2.4:1
Mean age (Years, SD) 12.2 0.6 2.5 6.9 15.2 36.1
Mean axillary temp (°C) [Range] 38.5 (36.0-41.2) 38.4 (36.5-40.6) 38.5 (36.0-41.2) 38.3 (36.3-40.5) 38.2 (36.0-41.0) 38.2 (36.0-40.5)
Malaria parasite density (GMPD)/μL 5420 5082 6397 2728 10734 2158
GMPD†† (95% CI) (2472-13981) (2583-10599) (4027-10428) (880-10207) (3912-33307) (956-5363)
Mean Hb (g/dl, range) 8.9 (1.6-17.6) 7.7 (2.2-15.4) 7.4 (1.6-15.6) 9.1 (4.0-14.3) 11.4 (4.3-17.6) 10.8 (2.9-16.9)
Malaria parasite prevalence (%) 57.7 58 (20.3) 121 (42.5) 27 (9.5) 39 (13.7) 40 (14.0)
Fever (axillary temp ≥ 37.5°C) % 348 (70.5) 78 (22.4) 130 (37.4) 26 (7.5) 40 (11.5) 74 (21.2)
Severe anaemia* (%) 72 (14.6) 21 (29.2) 37 (51.4) 3 (4.2) 5 (6.9) 6 (8.3)
Mild/moderate anaemia† (%) 273 (55.3) 64 (23.4) 114 (41.8) 24 (8.8) 24 (8.8) 47 (17.2)
Splenomegaly prevalence (%) 145 (29.3) 39 (26.9) 62 (42.8) 9 (6.2) 18 (12.4) 17 (11.7)
* Severe anaemia (Hb < 5 g/dL)
† Mild/moderate anaemia (Hb > 5 g/dl - Hb < 11 g/dL)
†† GMPD = Geometric mean parasite density among observed positive cases only.
Figure 1 Comparison of blood smear with fever episodes in
cases admitted for severe malaria by age groups
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of the 494 patients died during the one year period.
Most of the deaths occurred in patients from the urban
areas of Tanga city (81.2% vs 18.3%). Deaths reported
were of infants (12.5%), children aged 1-4 years (43.8%)
and adults (37.5%) of over 19 years of age, and all of the
deceased adults had negative BS for malaria parasites.
Only 6 out of these 16 (37.5%) deaths had positive BS
for malaria parasites of whom 2 were infants and 4 were
children aged 1-4 years.
Discussion
According to health facility statistics, malaria in Tanzania
is the leading cause of morbidity and mortality. Ministry
of Health data from 2003 show that around 30 per cent
of all hospital admissions and 15 per cent of all hospital
deaths in Tanzania are due to malaria [24]. Results
obtained in our study show that just over half of the
patients admitted in the 1 year period October 2004 to
September 2005 were cases of malaria. A case of malaria
requires the presence of parasites in the blood, supported
by fever or history of fever. Reyburn [25] recorded almost
similar findings in a study aimed at assessing the diagno-
sis and outcomes in patients admitted with a diagnosis of
severe malaria in north-eastern Tanzania. In the case of
fever in BS negative, infections other than malaria should
be considered as has been documented by Berkley [26] in
Kenyan children where various bacterial infections were
found to be responsible for the majority of childhood
deaths.
An interesting observation was that a considerable pro-
portion of patients with negative blood smear for malaria
parasites and without fever was also admitted as severe
cases of malaria. The inclusion of afebrile/apyrexic
patients and those with BS negative results for malaria
parasites as severe malaria shows that malaria is over-
reported in this health facility using clinical diagnosis as
the principal method of diagnosis. This is likely to occur
in most Sub-Saharan Africa and is facilitated through the
syndromic approach, popularly termed as integrated
management of childhood illness (IMCI) strategy [27],
which is not a precise way of diagnosing diseases [28,29].
Reyburn [25] had comparable findings where only 46.1%
of the clinically examined patients had positive blood
smears.
The high rate of cases with negative BS for malaria
parasites found in our study could have been attributed
to the inclusion of patients with acute febrile illnesses
caused by aetiologies other than malaria. This is similar
to what Njama-Meya [30] reported in a prospective
cohort study of malaria treatment restricted to labora-
tory-confirmed cases in Ugandan children in which 32%
of the febrile episodes were found positive for malaria.
This means that majority (68%) of the episodes attended
were caused by various other infections.
The proportion of cases with hypoglycaemia in our
study was relatively lower than those reported in other
areas of Sub-Sahara Africa. For instance, Taylor et al [31]
in a study to find out the clinical associations and rela-
tionship to quinine dosage of hypoglycaemia in severe
malaria in Malawi reported that 20% of children had
hypoglycaemia before treatment. In another study that
was conducted along the coastal areas of Kenya, English
et al [32] reported almost similar proportion (16%) of
hypoglycaemia in children on admission. So far, we can-
not identify the reasons for the lower proportion of hypo-
glycaemia recorded in patients in our study.
Moreover, the low sensitivity of laboratory techniques
used in diagnosing malaria could have played a part in the
increase of BS negative results. Microscopy has some tech-
nical drawbacks that make it less sensitive than polymer-
ase chain reaction (PCR) technique in the detection of
malaria parasites [33]. It has been noted that considerable
Table 2 Comparison of malaria clinical signs and symptoms with blood smear results in patients admitted for severe
malaria at Bombo hospital, Tanga, Tanzania
Clinical observation alone
Signs & symptoms Initial total cases*+ Reassessed cases (n,%)**+ No. +ve (n,%) Odds ratio P-value 95% CI
Clinical manifestations* 494 369 (74.7) 227 (61.5) 1.63 0.008 1.136 - 2.350
Cerebral malaria** 273 129 (47.3) 89 (69.0) 1.34 0.26 0.807 - 2.208
Severe anaemia 494 72 (14.6) 61 (84.7) 4.85 0.001 2.509 - 9.578
Hyperpyrexia† 494 97 (19.6) 59 (60.8) 1.17 0.486 0.746 - 1.849
Hyperparasitaemia†† 494 285 (57.7) 4 (1.4) 0.085
Convulsions 494 23 (4.7) 17 (73.9) 2.15 0.107 0.831 - 5.540
Jaundice 494 6 (1.2) 3 (50.0) 0.73 0.701 0.146 - 3.656
*+Initial total cases are those admitted with diagnosis of severe malaria from OPD.
**+Reassessed cases are those confirmed to have severe malaria by investigators.
*Clinical signs and symptoms used as inclusion criteria for severe malaria.
**According to the Blantyre coma score scale.
†Axillary temperature ≥ 39.5°C.
††Parasite count ≥ 250,000/μL of blood.
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number of parasites are lost during the staining process
[34-36], leading to either incorrect estimates of parasite
density or the smear being considered as negative in the
case of scanty or low parasitaemia, usually in densities of <
50 parasites/μL of blood [37,38]. Otherwise these children
had infections in other body systems causing illnesses
resembling severe malaria, e.g. septicaemia, pneumonia,
urinary tract infection, HIV/AIDS and other viral
infections.
According to the scores obtained with the Blantyre
coma scale, it seems that cerebral malaria is a common
manifestation of severe malaria among the under-fives in
this area. It was observed that among the sick children
assessed, 47.3% had altered consciousness indicative of
cerebral involvement, and about one third of these had
negative BS for malaria parasites. Considering the fact
that a case definition of malaria requires the presence of
asexual parasites in the blood[39,40], it is most likely that
the patients who had no parasitaemia could have other
infections with cerebral manifestations mimicking cere-
bral malaria, like cerebrospinal meningitis [41]. The pro-
portion of patients who had cerebral malaria (47.3%) was
actually higher than that recorded by Pankoui Mfonkeu
(20.2%) in Douala, Cameroon [42].
The considerable proportion of patients observed with
signs and symptoms of severe malaria, and others pre-
senting with hyperpyrexia (body temperature ≥ 39.5°C)
but having no parasitaemia indicates very serious
Table 3 Relationship between clinical conditions and presence of malaria parasites by age group
Age group
Signs/Symptoms Status Infants 1-4 yrs 5-9 yrs 10-19 yrs 20+ yrs
No 3 (20.0) 4 (33.3) 4 (50.0) 21 (56.8) 26 (49.1)
Severe clinical manifestations (%) Yes 12 (62.5) 117 (74.1) 23 (82.1) 18 (60.0) 14 (21.5)
P- value 0.002 0.003 0.064 0.789 0.002
No 20 (80.0) 30 (75.0) 7 (70.0) 16 (59.3) 12 (27.3)
Fever (Temp ≥ 37.5°, %) Yes 38 (48.7) 91 (70.0) 20 (76.9) 23 (57.5) 28 (37.8)
P- value 0.006 0.542 0.667 0.886 0.241
No 4 (58.6) 49 (66.2)
Cerebral malaria* (%) Yes 17 (51.5) 72 (75.0)
P- value 0.5 0.21
No 38 (46.3) 86 (64.7) 25 (75.8) 37 (59.7) 38 (33.9)
Severe anaemia (Hb < 5 g/dl, %) Yes 20 (95.2) 35 (94.6) 2 (66.7) 2 (40.0) 2 (33.3)
P- value 0.0001 0.0001 0.728 0.391 0.976
No 53 (55.8) 112 (72.3) 27 (75.0) 37 (56.9) 38 (33.0)
Convulsions (%) Yes 4 (66.7) 9 (69.2) 0 2 (100) 2 (100)
P- value 0.602 0.815 0.224 0.048
No 28 (43.8) 68 (63.0) 20 (74.1) 31 (63.3) 35 (34.7)
Splenomegaly prevalence (%) Yes 30 (76.9) 53 (85.5) 7 (77.8) 8 (44.4) 5 (29.4)
P- value 0.001 0.002 0.824 0.166 0.673
*Assessed by the Blantyre coma score scale.
Table 4 Comparison of duration of illness with blood smear results for malaria parasites
Variable Age group
Duration of illness (days) with BS positive Infants 1-4 years 5-9 years 10-19 years 20+ years Total
(%) (%) (%) (%) (%)
≤ 7 days 53 (20.6) 109 (42.4) 24 (9.3) 35 (13.6) 36 (14.0) 257
8-14 days 5 (25.0) 8 (40.0) 3 (15.0) 1 (5.0) 3 (15.0) 20
15+ days 0 4 (50.0) 0 3 (37.5) 1 (12.5) 8
Median duration (days) of illness [IQ range] 4[3-6] 4 [3,6] 6 [3,6] 4 [3-6] 4 [3-6]
Duration of illness (days) with BS negative Infants 1-4 years 5-9 years 10-19 years 20+ years Total
(%) (%) (%) (%) (%)
≤ 7 days 39 (25.2) 42 (27.1) 7 (4.5) 25 (16.1) 42 (27.1) 155
8-14 days 5 (22.7) 5 (22.7) 2 (9.1) 1 (4.6) 9 (40.9) 22
15+ days 1 (3.0) 2 (6.3) 0 2 (6.3) 27 (84.4) 33
Median duration (days) of illness [IQ range] 4[3- 7.0] 4 [3-7] 5 [5-7] 4.5 [3-7] 7 [4-33]
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diagnostic errors and case management problems in our
hospitals. In this study, for instance, 38.5% of patients
who presented with severe clinical signs and symptoms
of disease pertaining to severe malaria and 19.6% of
patients who had hyperpyrexia had no parasitaemia.
This in part is due to inadequate quality of care result-
ing from dependence on under-trained personnel for
most of the clinical work in most of our health facilities,
and absence of or insufficient laboratory diagnostic
services, particularly in the primary health care units
(Mangesho et al. in preparation). Unfortunately under-
trained personnel are normally the first to be consulted
even in most regional hospitals in Tanzania. It is true
that malaria is the leading cause of hospital attendances
and hospital admissions in Tanzania so far and probably
in sub-Saharan Africa as a whole. But the findings of
this study portray doubt on the reliability of the accu-
racy of data from health facilities.
Furthermore, severe anaemia also appeared to be a pro-
blem that was significantly associated with malaria (p =
0.001). The trend showed that where there was an
increase in the proportion of BS positive results for
malaria parasites, there was a corresponding increase in
the proportion of severe anaemia cases, and vice versa.
This phenomenon was more marked in children below
the age of five years who also happened to be the group
with the highest proportion of BS positive for malaria
parasites. In many malaria endemic countries anaemia
has been reported to be the most common complication
of falciparum malaria and one of the commonest causes
of deaths in children [5,43,44]. The overall prevalence of
malaria-related severe anaemia in our study was 14.6%,
which was almost threefold less compared to 46.0%
reported by Newton [45] in children along the coastal
area of Kenya between 1989 and 1991 and, by Dzeing-
Ella [21] in Gabon between 2000 and 2002, where preva-
lence of severe anaemia has been reported to be as high
as 67.%. In general, the prevalence of malaria-related
severe anaemia has a corresponding level with malaria
endemicity, for instance, Font [46] found that malaria
and anaemia were the main causes of referrals from rural
health facilities to the district hospital of Kilombero in
Tanzania. Effective malaria control interventions, particu-
larly the country-wide use of insecticide treated bed nets
[47,48] might have been responsible for the decline in
malaria prevalence recently reported in Tanzania [49],
resulting in a parallel decrease in the level of severe anae-
mia recorded in our study. However, despite the possible
association between malaria and anaemia, it is difficult to
draw a strong conclusion of malaria being the sole cause
and effect of anaemia due to its multi-factorial nature in
the tropical environment [50].
It has been noted that patients reported various dura-
tion of illness. Some had been sick for periods as short
as one day, whereas a number of them were unwell for
almost 3 months. Duration of illness documented in
adult patients (≥20 years) was noted to be significantly
long among those with negative BS, indicating that
some causes other than malaria, like HIV/AIDS, might
have been responsible for the sickness in this age group.
Low death rates might have resulted from good access
to health services for the majority of the patients living
within the city (as has been evidenced by the fact that
half of the patients already received some antimalarials
even before coming to hospital). Prompt treatment by
hospital staff due in part to over-diagnosis of malaria
[25] played a role in the low rate of malaria-specific
deaths. The use of quinine has proved to be very effec-
tive in reducing mortality in our study although recent
report indicates that artesunate performs better [51].
Almost half of the patients enrolled in our study had a
history of taking antimalarial drugs prior to admission.
These patients most likely got their medicines either from
low level health facilities before they were referred or they
might have obtained the drugs over the counter, which is
a common practice in Tanzania. Some studies conducted
in the country show that over 71% of patients treat them-
selves even before consulting a health facility [52,53].
Conclusions
The high proportion of fever cases in patients with BS
negative results for malaria parasites poses the question
as to what could be the actual cause of illness. There is a
need to find out if malaria still continues to be the lead-
ing cause of morbidity and mortality in Tanzania and
sub-Saharan Africa as is believed to be, particularly bear-
ing in mind the impact of HIV/AIDS. Use of more speci-
fic RDT might also help. This would reduce the problem
of over-diagnosis of malaria and bring about rational use
of antimalarials and other relatively expensive drugs. We
need to revisit the usefulness of IMCI in terms of its
impact on disease over-diagnosis and over-prescription
of drugs. Improvement of clinical and laboratory diagno-
sis of malaria is crucial for proper case management and
reliable data collection in the changing epidemiological
setting. Blood and urine culture tests could be an impor-
tant component of management of febrile illnesses in
general and cases of non malaria febrile illness in
particular.
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